Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Provectus Completes Liver Cancer Trial

January 27, 2011 7:13 am | News | Comments

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has completed patient accrual and treatment of all subjects in its Phase 1 clinical trial of PV-10 for liver cancer.

TOPICS:

RVX-208 Effects Alzheimer's Marker

January 27, 2011 7:11 am | News | Comments

Resverlogix announced that its lead drug RVX-208, a first in class ApoA-I production drug, illustrated positive effects on an important cognitive function and Alzheimer's Disease marker, plasma Amyloid beta 40.

TOPICS:

Judge Denies AstraZeneca Trial Request

January 27, 2011 7:00 am | News | Comments

A Franklin County, Ky., judge has denied a pharmaceutical company's request for a new trial in a case in which it has been ordered to pay $20.5 million over inflated prescription drug prices.

TOPICS:
Advertisement

BMS Profit Forecast Below Expectations

January 27, 2011 6:59 am | by Linda A. Johnson | News | Comments

Fourth-quarter profit plunged for Bristol-Myers Squibb Co. due to a huge gain a year ago, but higher U.S. sales and tight cost controls enabled the drugmaker to meet Wall Street's earnings expectations.

TOPICS:

Teva Buying Peruvian Pharma

January 27, 2011 6:57 am | News | Comments

Teva Pharmaceutical Industries Ltd. said it is expanding its business in Latin America by buying Peruvian drugmaker Corporación Infarmasa. Corporación Infarmasa is owned by The Rohatyn Group and Altra Investments.

TOPICS:

AstraZeneca Profits Take 5% Hit

January 27, 2011 6:55 am | by Robert Barr | News | Comments

Competition from generic drugs in the United States contributed to a 5 percent drop in net profit for AstraZeneca PLC in the fourth quarter, the pharmaceutical firm reported.

TOPICS:

FDA Panel Backs Acculink Expansion

January 27, 2011 6:53 am | News | Comments

A panel of experts on voted in favor of broadening approval of an Abbott Laboratories stent to more patients at risk of stroke. The Food and Drug Administration panel voted 7-3 that the benefits of Abbott's RX Acculink stent for patients at medium risk of stroke outweigh the risks.

TOPICS:

Novartis Profits Drop 2%

January 27, 2011 6:51 am | News | Comments

Swiss drug maker Novartis AG saw fourth quarter net profit slip 2 percent on the year to $2.32 billion amid one-off charges and a sharp drop in demand for its pandemic flu vaccine, the company said.

TOPICS:
Advertisement

FDA Sets Remoxy Decision Date

January 27, 2011 6:50 am | News | Comments

Federal regulators have accepted a resubmission from Pain Therapeutics Inc. and Durect Corp. for a potential pain reliever, the companies said. The Food and Drug Administration is scheduled to make a regulatory decision on the drug candidate by June 23.

TOPICS:

VDR Assay

January 26, 2011 7:33 am | Product Releases | Comments

An off-the-shelf solution for screening human vitamin D receptor (VDR) is now available from INDIGO Biosciences. INDIGO Nuclear Receptor Assay Kits are highly convenient and efficacious, going from freezer to data in 24 hours with minimal hands on time.

TOPICS:

Plate Washer

January 26, 2011 7:29 am | Product Releases | Comments

Tecan has developed the HydroSpeed plate washer, an advanced system for optimized washing of cells, beads and ELISAs in 96- and 384-well formats.

TOPICS:

Molecular Network Influences Leukemia Outcome

January 26, 2011 7:25 am | News | Comments

A study shows for the first time that the three most common chromosome changes seen in chronic lymphocytic leukemia disrupt a molecular network that includes several important genes and strongly influences the outcome of the disease.

TOPICS:

New Approach to TB Vaccination Tested

January 26, 2011 7:23 am | News | Comments

A team of U.S. and European researchers have found that a new vaccine strategy tested in mice provides stronger, more long-lasting protection from tuberculosis infection than the vaccine currently used in humans, known as BCG.

TOPICS:

Lilly to Report Earnings Thursday

January 26, 2011 7:16 am | News | Comments

The drugmaker Eli Lilly and Co. reports fourth-quarter results from 2010 on Thursday before the market opens. Analysts will be more concerned with how the Indianapolis drugmaker handles the next four years, as opposed to how it wrapped up 2010.

TOPICS:

Abbott Income Down 6%

January 26, 2011 7:12 am | News | Comments

Drug and medical device maker Abbott Laboratories said its fourth-quarter net income dropped 6 percent on costs connected with a number of acquisitions, but the results met Wall Street expectations.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading